Veru Inc.

NASDAQ:VERU

Biotechnology

Healthcare
$3.16 +4.33%

+$0.13 today

Market cap
$50.72M
Beta
-1.13
P/E (TTM)
-4.8
EPS (TTM)
-$0.65
52W Low $2.05High $7.33

Volume 0.34M

Average 1.82M

VERU Sales of Investments

Cash received from selling or redeeming investments.

Veru Inc.NASDAQ: VERU

Sales of Investments · Q2 FY2026 · quarter ended Mar 2026

Sales of investments outflow grows to $3.17M

Q2 FY2026 sales of investments was $3.17M, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $3.17M.

Context

  • Sales of investments increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly sales of investments holds near $3.17M or moves back toward the trailing-twelve-month quarterly average of $792.23K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.17M— QoQ
Last fiscal yearSep 2025
$393.22K— YoY
LTMMar 2026
$3.17M+705.9% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
393.22K USD
Year-over-year change
—

Sales of Investments vs competitors

How VERU compares with its peers on the latest reported figures

  • VERU's LTM Mar 2026 sales of investments of $3.17M is the 2nd largest of the 7 companies compared; the peer median is $0.
  • Its year-over-year change of +705.9% is the highest of 2, against a peer median of -8.1%.
VERU Competitors Peer median
Sales of Investments for VERU and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DYAIDyadic International, Inc.LTM Mar 2026$5.93M -8.1%-7.0%199.2%
VERUVeru Inc.LTM Mar 2026$3.17M +705.9%——
MAIAMAIA Biotechnology, Inc.LTM Mar 2026$0 ———
PYPDPolyPid Ltd.LTM Dec 2025$0 ———
ANVSAnnovis Bio, Inc.LTM Mar 2026$0 ———
RNXTRenovoRx, Inc.LTM Mar 2026$0 ——0.0%
CELUCelularity Inc.LTM Dec 2025$0 ——0.0%
Peer median (excluding VERU) $0-8.1%-7.0%0.0%

Competitors are the stored peer set for VERU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income7.39M(83.78M)(93.15M)(37.8M)(22.73M)
Depreciation & Amortization211.39K209.6K269.87K268.18K152.11K
Deferred Income Tax(3.57M)76.21K177.5K367.18K(1.92K)
Stock-Based Compensation5.05M11.24M17.92M13.64M8.1M
Change in Working Capital(7.28M)25.88M(15.15M)222.49K(4.13M)
Accounts Receivables(3.56M)4.54M(4.15M)546.2K(657.25K)
Inventory546.38K(3.13M)648.63K986.11K863.93K
Accounts Payables597.1K18.59M(7.43M)(5.43M)(2.76M)
Other Working Capital(4.86M)6.14M(4.22M)4.12M(1.58M)
Other Non-Cash Items(17.38M)(1.14M)1.92M1.62M(11.44M)
Operating Cash Flow(15.57M)(47.51M)(88.01M)(21.68M)(30.04M)
Capital Expenditures(376.65K)(733.05K)(665.7K)(158.32K)(1.08K)
Acquisitions (Net)15M5M0024.75M
Purchases of Investments00000
Sales of Investments0000393.22K
Other Investing Activities007M304.54K0
Investing Cash Flow14.62M4.27M6.33M146.21K25.14M
Debt Repayment(19.44K)(9.09K)132.98K(132.98K)(4.22M)
Common Stock Issued108.1M1.08M6.01M35.3M0
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities1.64M04.97M1.66M0
Financing Cash Flow109.72M1.07M11.11M36.83M(4.22M)
Effect of Forex Changes00000
Net Change in Cash108.77M(42.17M)(70.57M)15.29M(9.12M)
Free Cash Flow(15.95M)(48.24M)(88.68M)(21.84M)(30.04M)

Veru Inc.

NASDAQ:VERU

Intrinsic Alpha fair value

Locked

Current Price

$3.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.